Lisanti Capital Growth, LLC Abiomed Inc Transaction History

Lisanti Capital Growth, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 05, 2018	SELL	$354.53 - $449.75 $1.24 Million - $1.57 Million	-3,490 Closed	0 $0
Q2 2018 Aug 13, 2018	SELL	$278.07 - $446.21 $411,543 - $660,390	-1,480 Reduced 29.78%	3,490 $1.43 Million
Q1 2018 May 15, 2018	BUY	$192.49 - $295.85 $292,584 - $449,692	1,520 Added 44.06%	4,970 $1.45 Million
Q4 2017 Feb 07, 2018	SELL	$168.78 - $199.74 $7,595 - $8,988	-45 Reduced 1.29%	3,450 $647,000
Q3 2017 Nov 13, 2017	BUY	$145.39 - $168.6 $508,138 - $589,257	3,495	3,495 $589,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Lisanti Capital Growth, LLC, based on Form 13F filings with the SEC.

Stay updated on Lisanti Capital Growth, LLC with notifications on news.